B I Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Washington, DC and active since 2010.
B I Pharmaceuticals was established in 2010, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Paul Romness, Vice President at the company’s single location by writing to 1120 G St Nw, Washington, District of Columbia DC 20005 or by phoning (202) 347-8270. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | B I Pharmaceuticals |
| Contact Person: | Paul Romness, Vice President |
| Address: | 1120 G St Nw, Washington, District of Columbia 20005 |
| Phone Number: | (202) 347-8270 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
B I Pharmaceuticals was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Paul Romness, Vice President for inquiries that concern B I Pharmaceuticals by calling the company number (202) 347-8270, as your correspondence is most welcome. Additionally, the physical location of the single location of B I Pharmaceuticals can be found at the coordinates 38.89825,-77.02777 as well as the street address 1120 G St Nw in Washington, District of Columbia 20005.
For its online presence, you may visit B I Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.